ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,291.34
      0.15%
      US Tech 100
      18,178.56
      0.29%
      Dow Jones
      38,711.29
      0.36%
      Brent Oil
      77.11
      -1.32%
      Bitcoin
      70,531.34
      2.51%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Intercept Pharmaceuticals Inc (ICPT)

      7. Intercept Pharmaceuticals Inc (ICPT) News

      ICPT

      Intercept Pharmaceuticals (ICPT)

      Intercept Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ICPT
      DateTimeSourceHeadlineSymbolCompany
      1:08PMiHub NewswireFeaturedElement79 Gold Corp Continues Fostering Local Community Engagement
      05/09/20248:00AMGlobeNewswire Inc.Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 ConferenceNASDAQ:ICPTIntercept Pharmaceuticals Inc
      02/29/20248:30AMGlobeNewswire Inc.Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBCNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/20/202312:09PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/15/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/15/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20232:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/13/20238:00AMGlobeNewswire Inc.Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023NASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/10/20238:00AMGlobeNewswire Inc.Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023NASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:28PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:28PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:26PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
      11/08/20234:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ICPT